1. Beriwal S, Bhatnagar A, Heron D et al. High dose rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy 2006; 5: 218-222.
2.
Pinn-Bingham M, Puthawala A, Syed N et al. Outcomes of high dose rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long term results. Int Radiat Oncol Biol Phys 2013; 85: 714-720.
3.
Viswanathan A, Szymonifka J, Tempary-Afdhal C et al. A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy. Brachytherapy 2013; 12: 240-247.
4.
Yoshida K, Yamazaki H, Takenaka T et al. Preliminary results of MRI-assisted high dose rate interstitial brachytherapy for uterine cervical cancer. Brachytherapy 2015; 14: 1-8.
5.
Goodman C, Mendez L, Velker W et al. 3D image-guided interstitial brachytherapy for primary vaginal cancer: A multi-institutional experience. Gynecol Oncol 2021; 160: 134-139.
6.
Gutiérrez Miguélez C, Rodríguez Villalba C, Villafranca Iturre E et al. Recommendations of the Spanish brachytherapy group of the Spanish Society of Radiation Oncology and the Spanish Society of Medical Physics for interstitial high-dose-rate brachytherapy for gynaecologic malignancies. Clin Transl Oncol 2023; 25: 912-932.
7.
Mahantshetty U, Kashid UR, Mulye G et al. Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers. Brachytherapy 2023; S1538-4721(23)01599-4.
8.
Pötter R, Tanderup K, Schmid MP, et al. EMBRACE collaborative group. MRI guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 2021; 22: 538-547.
9.
Martinez A, Cox R, Edmundson G. A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal and gynecologic malignancies. Int J Radiat Oncol Biol Phys 1984; 10: 297-305.
10.
Syed A, Puthawala A, Neblett D et al. Transperineal interstitial intracavitary “Syed-Neblett” applicator in the treatment of carcinoma of the uterine cervix. Endocuriether Hypertherm 1986; 2: 1-13.
11.
Viswanathan A, Thomadsen B. American Brachytherapy society: consensus guidelines for locally advanced carcinoma of the cervix. Part I: General principles. Brachytherapy 2012; 11: 33-46.
12.
Haie-Meder C, Pötter R, Van Limbergen E et al. Recommendations from Gynecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-245.
13.
Pötter R, Haie-Meder C, Van Limbergen E et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77.
14.
Rodriguez Villalba S, Richart Sancho J, Otal Palacin A et al. A new template for MRI-based intracavitary/interstitial gynecologic brachytherapy: design and clinical implementation. J Contemp Brachytherapy 2015; 7: 265-272.
15.
Rodriguez Villalba S, Otal Palacín A, Richart Sancho J et al. Pre-plan technique feasibility in multi-interstitial/endocavitary perineal gynecological brachytherapy. J Contemp Brachytherapy 2017; 9: 472-476.
16.
Richart Sancho J, Otal A, Rodriguez Villalba S et al. A practical MRI-based reconstruction method for a new endocavitary and interstitial gynaecological template. J Contemp Brachytherapy 2015; 7: 407-414.
17.
Richart Sancho J, Carmona-Meseguer V, García-Martínez T et al. Review of strategies for MRI based reconstruction of endocavitary and interstitial applicators in brachytherapy of cervical cancer. Rep Pract Oncol Radiother 2018; 23: 547-561.
18.
Perez-Calatayud J, Colmenares Fernández R, García Martínez T et al. Consideraciones prácticas en la implementación de la Resonancia Magnética en la planificación en braquiterapia ginecológica de cérvix. Informe del Grupo de Trabajo de Braquiterapia de la Sociedad Española de Física Médica. Rev Fis Med 2018; 19: 29-72.
19.
Otal A, Richart J, Rodriguez S, Santos M, Perez-Calatayud J. A method to incorporate interstitial components into the TPS gynecologic rigid applicator library. J Contemp Brachytherapy 2017; 9: 59-65.
20.
Otal A, Celada F, Chimeno J et al. Review on treatment planning systems for cervix brachytherapy (interventional radiotherapy): Some desirable and convenient practical aspects to be implemented from radiation oncologist and medical physics perspectives. Cancers 2022; 14: 3467.
21.
International Study on MRI-Guided Brachytherapy in Locally Advance Cervical Cancer [Sede Web]. Medical University of Vienna [acceso 3 de febrero de 2024]. Disponible en: https://www.embracestudy.dk
22.
The American Brachytherapy Society Treatment Recommendations for Locally Advanced Carcinoma of the Cervix Part II: High dose-rate brachytherapy. Brachytherapy 2012; 11: 47-52.
23.
Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute.
24.
Kamrava M, Beriwal S, Erickson B et al. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. Brachytherapy 2017; 16: 1129-1143.
25.
Kamrava M, Leung E, Bachand et al. GEC-ESTRO (ACROP)-ABS-CBG consensus brachytherapy target definition guidelines for recurrent endometrial and cervical tumors in the vagina. Int J Radiat Oncol Biol Phys 2023; 115: 654-663.
26.
Bajwa H, Singareddy R, Raju AK et al. Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies. Brachytherapy 2020; 19: 669-673.
27.
Flower F, Zanjani S, Busuttil G et al. A single-institution review of image-guided brachytherapy for vaginal malignancies using customized molded applicators and interstitial needles. J Contemp Brachytherapy 2021; 13: 663-669.
28.
Huang J, DeCesaris CM, Sarkar V et al. Image-guided preplanning workflow for high-dose-rate interstitial brachytherapy for gynecological malignancies. Brachytherapy 2024; 23: 25-34.
29.
Pötter R, Tanderup K, Schmid MP et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 2021; 22: 538-547.
30.
Sturdza A, Pötter R, Fokdal LU et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120: 428-433.
31.
Beriwal S, Demanes J, Erickson B et al. American Brachytherapy Society consensus guide- lines for interstitial brachytherapy for vaginal cancer. Brachytherapy 2012; 11: 68-75.
32.
Mahantshetty U, Gudi S, Singh R et al. Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy. J Contemp Brachytherapy 2019; 11: 293-306.
33.
Sood S, Gurram L, Aravindakshan D et al. Reporting of dose-volume specifications for “Martinez Universal Perineal Interstitial Template-based interstitial high-dose-rate brachytherapy for gynecological cancers” according to International Commission on Radiation Units and Measurements 58 with early clinical outcomes. Brachytherapy 2021; 20: 550-556.
34.
Kotsuma T, Yoshida K, Yamazaki H et al. Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgery. J Radiat Res 2011; 52: 329-334.
35.
Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 2003; 56: 1366-1372.
36.
Vargo JA, Kim H, Houser CJ et al. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification. Radiother Oncol 2014; 113: 126e131.
37.
Lee LJ, Damato AL, Viswanathan AN. Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer. Gynecol Oncol 2013; 131: 586e592.
38.
Fokdal L, Ørtoft G, Hansen ES et al. Toward four-dimensional image- guided adaptive brachytherapy in locally recurrent endometrial cancer. Brachytherapy 2014; 13: 554e561.
39.
Wang F, Bu L, Wu Q et al. Comparison of computed tomography- and magnetic resonance imaging-based target delineation for cervical cancer brachytherapy. J Contemp Brachytherapy 2020; 12: 367-374.
40.
Viswanathan AN, Dimopoulos J, Kirisits C et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007; 68: 491-498.
41.
Eskander RN, Scanderbeg D, Saenz CC et al. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring. Int J Gynecol Cancer 2010; 20: 47-53.
42.
Wang F, Tang Q, Lv G et al. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy: A systematic review. Brachytherapy 2017; 16: 353-365.
43.
Prescribing, recording, and reporting brachytherapy for cancer of the cervix. J ICRU 2013; 13: NP.
44.
Lee LJ, Viswanathan AN. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer. Int J Radiat Oncol Biol Phys 2012; 84: 1192-1197.
45.
Chopra S, Dora T, Engineer R et al. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥ II toxicity. Brachytherapy 2015; 14: 881-888.
46.
Mulye G, Gurram L, Chopra S et al. Clinical outcomes of patients treated with template based high-dose-rate interstitial brachytherapy boost for post-operative recurrent gynecological malignancies: A retrospective analysis. J Contemp Brachytherapy 2022; 14: 560-567.
47.
Kanemoto A, Sugita T, Ayukawa F et al. Clinical results of image-guided interstitial brachytherapy with or without external beam radiotherapy for postsurgical vaginal recurrence of cervical and endometrial cancers. Jpn J Radiol 2022; 40: 639-644.
